Cannabis
Search documents
On Cannabis, Responsibility, and Leadership that Chose Reform Over Fear
International Business Times· 2026-01-08 20:14
Core Insights - The cannabis industry has seen a shift from fear-based federal policies to evidence-based reforms, highlighting the need for responsible cannabis policy that balances access with education and accountability [5][6][10][12] Group 1: Cannabis Policy and Reform - Federal cannabis policy historically relied on fear, leading to overcriminalization and negative impacts on communities [5] - The 2018 Farm Bill, signed by President Trump, legalized industrial hemp and marked a pragmatic shift in drug policy, promoting economic opportunities and state autonomy [6][7] - The Trump administration's approach respected states' rights, allowing local governance to inform effective cannabis regulation [7] Group 2: Personal Experience and Insights - Regular cannabis use can lead to diminished clarity, motivation, and emotional presence, with consequences that may not be immediately apparent [3][9] - Acknowledging the risks associated with habitual cannabis consumption, especially for young people, is essential for comprehensive reform [10] - The importance of discipline, accountability, and clear boundaries in personal and professional life has been reinforced through stepping away from cannabis [11] Group 3: Future Directions - Cannabis policy is at a crossroads, with the potential to either repeat past mistakes or continue evidence-based reforms [12] - Meaningful change requires accountability and the willingness to adjust policies based on real-world outcomes [12]
VFF's Cannabis Business Gains Scale: What's Fueling the Growth?
ZACKS· 2026-01-08 14:55
Key Takeaways Village Farms expanded cannabis operations in Q3, with the segment a key contributor.VFF's Canadian net sales rose 29% to $46.6 million as the mix shifted to higher-margin products.VFF saw export sales surge 758%, led by Germany, while the Netherlands facility ran full.Village Farms International (VFF) continued to expand its cannabis operations in the third quarter of 2025, driven by stronger performance in Canada and a sharp increase in international medical cannabis exports. During the quar ...
Curaleaf Announces Proposed Domestication to Delaware
Prnewswire· 2026-01-08 12:45
Core Viewpoint - Curaleaf Holdings, Inc. plans to seek shareholder approval for a proposed arrangement to continue its operations from British Columbia, Canada to Delaware, United States, which is expected to enhance its strategic objectives and streamline its organizational structure [1][2]. Group 1: Proposed Arrangement - The proposed arrangement includes the continuation of Curaleaf from British Columbia to Delaware, with all existing subordinate voting shares being converted to Delaware subordinate voting shares [2]. - The arrangement will not result in any material changes to the Company's business or operations [3]. Group 2: Shareholder Approval Process - Curaleaf intends to send a management information circular to shareholders and hold a special meeting on or about February 23, 2026, to seek approval for the arrangement [4]. - Approval requires a two-thirds majority (66 2/3%) of the votes cast by holders of subordinate voting shares and multiple voting shares [5]. Group 3: Implementation and Future Steps - The board of directors will determine the timing for implementing the arrangement, subject to necessary approvals, and may choose not to proceed if it is not in the best interests of the Company [6]. - After the arrangement, the Delaware subordinate voting shares are expected to continue trading on the Toronto Stock Exchange and OTCQX under the same trading symbols [7].
Tilray Brands, Inc. (NASDAQ: TLRY) Sees Positive Analyst Sentiment and Strategic Growth
Financial Modeling Prep· 2026-01-08 02:00
Core Insights - Tilray Brands, Inc. is a significant player in the cannabis industry, involved in research, cultivation, production, marketing, and distribution of medical cannabis products [1] - The company operates across multiple segments, including Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business, catering to a diverse customer base [1] Price Target and Analyst Sentiment - The consensus price target for Tilray has increased from $4.5 to $10 over the past year, indicating growing optimism among analysts [2] - Analyst John Zamparo from CIBC has set a more conservative price target of $8, reflecting a cautious approach ahead of the company's second-quarter earnings results scheduled for January 8, 2025 [2] Strategic Expansions and Stock Performance - Tilray's strategic expansions and partnerships in the beverage alcohol and wellness sectors have positively influenced stock sentiment [3] - The company's stock value has nearly tripled over the past six months, driven by the anticipation of cannabis reclassification in the United States, which is expected to significantly benefit cannabis growers like Tilray [3] Financial Performance - Recent earnings reports have shown improvements in revenue and profitability, supported by strong sales in both the cannabis and beverage alcohol segments [4] - The financial strength of Tilray is crucial as the cannabis industry continues to grow, driven by increasing consumer demand and the adoption of medical cannabis [4] Product Innovation - Product innovation is a key focus for Tilray, with new offerings such as GMP-certified flowers, oils, vapes, edibles, and topicals [5] - These innovations help Tilray maintain its competitive edge and attract a broader customer base in the evolving cannabis industry [5]
Blüm Holdings Announces $3.05 Million Debt Conversion
Globenewswire· 2026-01-07 22:00
Core Viewpoint - Blum Holdings, Inc. has successfully converted approximately $3.05 million of outstanding indebtedness into common stock, simplifying its capital structure and reducing legacy obligations [1][2][4] Group 1: Debt Conversion Details - The conversion was executed at a fixed price of $0.98 per share, equating to 85% of a $20.9 million pre-money valuation on a fully diluted basis, resulting in the issuance of 3,248,547 shares of common stock [2] - The converted debt was fully cancelled and satisfied, significantly reducing the company's legacy unsecured obligations [2] Group 2: New Financing Arrangement - In conjunction with the debt conversion, Blum Holdings executed a $525,000 senior secured promissory note, consolidating two previously issued unsecured notes [3] - The new note carries an interest rate of 8.0% per annum, matures on December 31, 2027, and is secured by substantially all of the company's assets, with the option for prepayment without penalty [3] Group 3: Company Overview - Blum Holdings is a leader in the cannabis sector, operating dispensaries throughout California and owning several prominent brands, including Korova, known for high potency products [5] - The company aims to leverage its ecosystem to enhance customer and retail investor acquisition, increase brand awareness, and create value across its portfolio [5]
Should You Buy ACB Stock After Marijuana Reclassification Order?
ZACKS· 2026-01-07 14:40
Key Takeaways ACB's medical cannabis revenues rose nearly 25% to C$135.3M, making up 72% of net revenues.Aurora Cannabis saw higher international sales lift margins and helped adjusted EBITDA jump 92% to C$26.2M.ACB is scaling back low-margin consumer cannabis as competition and price pressure weigh on that segment.Aurora Cannabis (ACB) sits at the intersection of a shifting regulatory landscape as the Trump administration moves to reclassify marijuana. While the decision marks a constructive step for the c ...
Ovation Science Secures New Canadian Patent; Strengthening IP Position and Expanding Commercial Opportunities for Topical Cannabis Products
Accessnewswire· 2026-01-07 13:00
Canadian Patent Enhances Market Exclusivity and Licensing Potential Expands Global Intellectual Property Portfolio Supporting Long-Term Revenue Growth VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company"), a research and development company focused on the commercialization, patenting, and licensing of advanced cannabinoid-based topical / transdermal products, today announced the issuance of a new Canadian patent covering proprietary ...
Tilray Inc. (NASDAQ: TLRY) Quarterly Earnings Preview
Financial Modeling Prep· 2026-01-07 11:00
Earnings Per Share (EPS) is expected to be -$0.14, indicating a significant improvement from the previous year's loss of $1.Revenue is projected at $211.1 million, slightly above the Zacks Consensus Estimate, showing a minor decline from the previous year.The company's financial health is highlighted by a low debt-to-equity ratio of 0.15 and a current ratio of 2.62, suggesting strong short-term financial stability.Tilray Inc. (NASDAQ: TLRY) is a prominent player in the Canadian cannabis industry, set to rel ...
Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 Earnings - Tilray Brands (NASDAQ:TLRY)
Benzinga· 2026-01-07 05:43
Core Insights - Tilray Brands, Inc. is expected to report a quarterly loss of 20 cents per share for Q2 2025, compared to a loss of 3 cents per share in the same quarter last year [1] - The consensus estimate for Tilray Brands' quarterly revenue is $210.95 million, which remains unchanged from the previous year [1] - Following President Trump's executive order to expedite the rescheduling of marijuana to a Schedule III substance, Tilray's shares fell by 2.5% to close at $9.26 [2] Analyst Ratings - Analyst Pablo Zuanic from Zelman & Assoc maintained a Neutral rating on Tilray Brands as of July 29, 2025, with an accuracy rate of 52% [4] - Analyst Michael Lavery from Piper Sandler also maintained a Neutral rating but reduced the price target from $2 to $1 on April 9, 2025, with an accuracy rate of 63% [4]
Power now drives markets: Axel Merk warns post-WWII era is over
KITCO· 2026-01-06 22:50
Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing a wealth of experience in journalism, particularly in finance and current affairs [1][5] Group 1: Career Background - Jeremy began his journalism career in 2006 at CTV, initially focusing on entertainment before transitioning to business reporting, particularly in mining and small-cap sectors [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Group 2: Digital Media Ventures - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers and positioned him as a prominent voice in the cannabis industry [4] - Following this success, he established Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap markets [4] Group 3: Professional Expertise - Jeremy has served as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods (CPG), and technology sectors [5] - He holds a BA in Journalism from Concordia University, which has supported his diverse career trajectory [5]